Russell E. Ware, MD, PhD is a highly experienced pediatric hematologist with over 30 years of practice, specializing in the evaluation and management of hematological disorders in children. His primary focus is on sickle cell anemia and other hemolytic anemias, as well as anemia, neutropenia, and thrombocytopenia. Dr. Ware is dedicated to improving the lives of young patients through his clinical care, laboratory investigations, and research on the use of hydroxyurea for sickle cell anemia treatment.
As the Director of the Division of Hematology and Co-Executive Director of the Cancer and Blood Diseases Institute at Cincinnati Children's Hospital, Dr. Ware is actively involved in transforming the clinical care of children with sickle cell anemia worldwide. His research includes NIH-funded trials of hydroxyurea to prevent stroke in children with sickle cell anemia, as well as investigating its use in low-resource settings in sub-Saharan Africa and the Caribbean. Dr. Ware's goal is to optimize hydroxyurea treatment for each patient and establish productive global partnerships to improve the diagnosis and treatment of sickle cell anemia globally.
Generated from the website